Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage
Bode M, Herrnstadt G, Dreher L, Ehnert N, Kirkerup P, Lindenmeyer M, Meyer-Schwesinger C, Ehmke H, Köhl J, Huber T, Krebs C, Steinmetz O, Wiech T, Wenzel U
HYPERTENSION. 2024;81(1):138-150.

Role of the anaphylatoxin receptor C5aR2 in angiotensin II induced hypertension and hypertensive end organ damage
Dreher L, Bode M, Ehnert N, Meyer-Schwesinger C, Wiech T, Köhl J, Huber T, Freiwald T, Herrnstadt G, Wenzel U
AM J HYPERTENS. 2024;37(10):810-825.

Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis
Engesser J, Khatri R, Schaub D, Zhao Y, Paust H, Sultana Z, Asada N, Riedel J, Sivayoganathan V, Peters A, Kaffke A, Jauch-Speer S, Goldbeck-Strieder T, Puelles V, Wenzel U, Steinmetz O, Hoxha E, Turner J, Mittrücker H, Wiech T, Huber T, Bonn S, Krebs C, Panzer U
NAT COMMUN. 2024;15(1):8220.

Complement component C3 as a new target to lower albuminuria in hypertensive kidney disease
Bode M, Diemer J, Luu T, Ehnert N, Teigeler T, Wiech T, Lindenmeyer M, Herrnstadt G, Bülow J, Huber T, Tomas N, Wenzel U
BRIT J PHARMACOL. 2023;180(18):2412-2435.

2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action
Campbell N, Whelton P, Orias M, Wainford R, Cappuccio F, Ide N, Neal B, Cohn J, Cobb L, Webster J, Trieu K, He F, McLean R, Blanco-Metzler A, Woodward M, Khan N, Kokubo Y, Nederveen L, Arcand J, MacGregor G, Owolabi M, Lisheng L, Parati G, Lackland D, Charchar F, Williams B, Tomaszewski M, Romero C, Champagne B, L'Abbe M, Schlaich M, Fogo A, Feigin V, Akinyemi R, Inserra F, Menon B, Simas M, Neves M, Hristova K, Pullen C, Pandeya S, Ge J, Jalil J, Wang J, Wideimsky J, Kreutz R, Wenzel U, Stowasser M, Arango M, Protogerou A, Gkaliagkousi E, Fuchs F, Patil M, Chan A, Nemcsik J, Tsuyuki R, Narasingan S, Sarrafzadegan N, Ramos M, Yeo N, Rakugi H, Ramirez A, Álvarez G, Berbari A, Kim C, Ihm S, Chia Y, Unurjargal T, Park H, Wahab K, McGuire H, Dashdorj N, Ishaq M, Ona D, Mercado-Asis L, Prejbisz A, Leenaerts M, Simão C, Pinto F, Almustafa B, Spaak J, Farsky S, Lovic D, Zhang X
J HUM HYPERTENS. 2023;37(6):428-437.

Left ventricular myocardial strain responding to chronic pressure overload in patients with resistant hypertension evaluated by feature-tracking CMR
Chen H, Brunner F, Özden C, Wenzel U, Neumann J, Erley J, Saering D, Muellerleile K, Maas K, Schoennagel B, Cavus E, Schneider J, Blankenberg S, Koops A, Adam G, Tahir E
EUR RADIOL. 2023;33(9):6278-6289.

Human Leucocyte Antigen-Matching Can Improve Long Term Outcome of Renal Allografts from Donors Older Than 75 Years
Koch M, Zecher D, Lopau K, Weinmann-Menke J, Schulze A, Nashan B, Wenzel U, Banas B, Zeier M, Thaiss F, Sommerer C
TRANSPL P. 2023;55(2):309-316.

Was ist besser: Chlorthalidon oder Hydrochlorothiazid?
Krämer B, Hausberg M, Kreutz R, Wenzel U
MMW Fortschr Med. 2023;165(7):69-72.

CD4+ T cells produce GM-CSF and drive immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12
Paust H, Song N, De Feo D, Asada N, Tuzlak S, Zhao Y, Riedel J, Hellmig M, Sivayoganathan A, Peters A, Kaffke A, Borchers A, Wenzel U, Steinmetz O, Tiegs G, Meister E, Mack M, Kurts C, von Vietinghoff S, Lindenmeyer M, Hoxha E, Stahl R, Huber T, Bonn S, Meyer-Schwesinger C, Wiech T, Turner J, Becher B, Krebs C, Panzer U
SCI TRANSL MED. 2023;15(687):.

Glucocorticoids target the CXCL9/CXCL10-CXCR3 axis and confer protection against immune-mediated kidney injury
Riedel J, Robben L, Paust H, Zhao Y, Asada N, Song N, Peters A, Kaffke A, Borchers A, Tiegs G, Seifert L, Tomas N, Hoxha E, Wenzel U, Huber T, Wiech T, Turner J, Krebs C, Panzer U
JCI INSIGHT. 2023;8(1):.

Increased blood pressure after nonsevere COVID-19
Schmidt-Lauber C, Alba Schmidt E, Hänzelmann S, Petersen E, Behrendt C, Twerenbold R, Blankenberg S, Huber T, Wenzel U
J HYPERTENS. 2023;41(11):1721-1729.

Die neuen Empfehlungen zur Hypertonietherapie
van der Giet M, Limbourg F, Vonend O, Wenzel U
MMW Fortschr Med. 2023;165(13):56-61.

Mosaic theory revised: inflammation and salt play central roles in arterial hypertension
Hengel F, Benitah J, Wenzel U
CELL MOL IMMUNOL. 2022;19(5):561-576.

Arterielle Hypertonie – Eine Übersicht für den ärztlichen Alltag
Hengel F, Sommer C, Wenzel U
DEUT MED WOCHENSCHR. 2022;147(7):414-428.

An Unsuspected Histological Finding in a Patient with Cancer and AKI
Hengel F, Wiech T, Wenzel U
KIDNEY360. 2022;3(11):1996-1997.

Cross-sectional study on the association of periodontitis with arterial hypertension in the Hamburg City Health Study
Könnecke H, Schnabel R, Walther C, Lamprecht R, Heydecke G, Seedorf U, Jagodzinski A, Borof K, Zeller T, Beikler T, Smeets R, Gosau M, Behrendt C, Wenzel U, Börschel C, Karakas M, Blankenberg S, Aarabi G
EUR J MED RES. 2022;27(1):.

Association between periodontitis and metabolic syndrome in the Hamburg City Health Study
Kotin J, Walther C, Wenzel U, Zyriax B, Borof K, Schnabel R, Seedorf U, Jagodzinski A, Heydecke G, Lamprecht R, Smeets R, Beikler T, Aarabi G
J PERIODONTOL. 2022;93(8):1150-1160.

Emerging fields for therapeutic targeting of the aldosterone-mineralocorticoid receptor signaling pathway
Lother A, Jaisser F, Wenzel U
BRIT J PHARMACOL. 2022;179(13):3099-3102.

Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage
Luettges K, Bode M, Diemer J, Schwanbeck J, Wirth E, Klopfleisch R, Kappert K, Thiele A, Ritter D, Foryst-Ludwig A, Kolkhof P, Wenzel U, Kintscher U
AM J NEPHROL. 2022;53(7):552-564.

The role of the mineralocorticoid receptor in immune cells in cardiovascular disease
van der Heijden C, Bode M, Riksen N, Wenzel U
BRIT J PHARMACOL. 2022;179(13):3135-3151.

Efficiency of Percutaneous Stent Angioplasty in Renal Artery Stenosis - 15 Years of Experience at a Single Center
Guerreiro H, Avanesov M, Dinnies S, Sehner S, Schön G, Wenzel U, Adam G, Ittrich H, Regier M
ROFO-FORTSCHR RONTG. 2021;193(3):298-304.

Behandlungsstrategien bei ausgeprägter Hyponatriämie
Kylies D, Wenzel U
DEUT MED WOCHENSCHR. 2021;146(9):573-574.

Immune Thrombocytopenic Purpura after vaccination with COVID-19 Vaccine (ChAdOx1 nCov-19)
Paulsen F, Schaefers C, Langer F, Frenzel C, Wenzel U, Hengel F, Bokemeyer C, Seidel C
BLOOD. 2021;138(11):996-999.

Immune mechanisms in arterial hypertension. Recent advances
Wenzel U, Ehmke H, Bode M
CELL TISSUE RES. 2021;385(2):393-404.

The role of complement in arterial hypertension and hypertensive end organ damage
Wenzel U, Kemper C, Bode M
BRIT J PHARMACOL. 2021;178(14):2849-2862.

Canonical and non-canonical functions of the complement system in health and disease
Wenzel U, Kemper C, Köhl J
BRIT J PHARMACOL. 2021;178(14):2751-2753.

ACE2 and SARS-CoV-2 - tissue or plasma, good or bad?
Wenzel U, Kintscher U
AM J HYPERTENS. 2021;34(3):274-277.

A high-salt diet compromises antibacterial neutrophil responses through hormonal perturbation
Jobin K, Stumpf N, Schwab S, Eichler M, Neubert P, Rauh M, Adamowski M, Babyak O, Hinze D, Sivalingam S, Weisheit C, Hochheiser K, Schmidt S, Meissner M, Garbi N, Abdullah Z, Wenzel U, Hölzel M, Jantsch J, Kurts C
SCI TRANSL MED. 2020;12(536):.

Hyponatriämie – Diagnose und Therapie
Kylies D, Wenzel U
DEUT MED WOCHENSCHR. 2020;145(21):1573-1579.

B6.Rag1 Knockout Mice Generated at the Jackson Laboratory in 2009 Show a Robust Wild-Type Hypertensive Phenotype in Response to Ang II (Angiotensin II)
Seniuk A, Thiele J, Stubbe A, Oser P, Rosendahl A, Bode M, Meyer-Schwesinger C, Wenzel U, Ehmke H
HYPERTENSION. 2020;75(4):1110-1116.

Die Nationale Bluthochdruckstrategie der DHL®
Wenzel U
MMW Fortschr Med. 2020;162(3):62-65.

Die renale Denervierung - eine akademische Spielerei? : Hypertonietherapie -- Autor: U. Wenzel
Wenzel U
MMW Fortschr Med. 2020;162(17):63-67.

Adaptive immunity and IL-17A are not involved in the progression of chronic kidney disease after 5/6 nephrectomy in mice
Rosendahl A, Kabiri R, Bode M, Cai A, Klinge S, Ehmke H, Mittrücker H, Wenzel U
BRIT J PHARMACOL. 2019;176(12):2002-2014.

Effect of renal denervation procedure on left ventricular mass, myocardial strain and diastolic function by CMR on a 12-month follow-up
Tahir E, Koops A, Warncke M, Starekova J, Neumann J, Waldeyer C, Avanesov M, Lund G, Fischer R, Adam G, Blankenberg S, Wenzel U, Brunner F
JPN J RADIOL. 2019;37(9):642-650.

Salt, inflammation, IL-17 and hypertension
Wenzel U, Bode M, Kurts C, Ehmke H
BRIT J PHARMACOL. 2019;176(12):1853-1863.

The chemokine receptor CX3CR1 reduces renal injury in mice with angiotensin II induced hypertension
Ahadzadeh E, Rosendahl A, Czesla D, Steffens P, Prüßner L, Meyer-Schwesinger C, Wanner N, Paust H, Huber T, Stahl R, Wiech T, Kurts C, Seniuk A, Ehmke H, Wenzel U
AM J PHYSIOL-RENAL. 2018;315(6):F1526-F1535.

ATP6AP2 over-expression causes morphological alterations in the hippocampus and in hippocampus-related behaviour
Bracke A, Schäfer S, von Bohlen Und Halbach O, Klempin F, Bente K, Bracke K, Staar D, van den Brandt J, Harzsch S, Bader M, Wenzel U, Peters J, von Bohlen Und Halbach O
BRAIN STRUCT FUNCT. 2018;223(5):2287-2302.

Kreatininanstieg in der Frühphase nach Nierentransplantation: Es muss nicht immer Abstoßung sein …
Kluger M, Person F, Wenzel U, Steinmetz O
NEPHROLOGE. 2018;13(1):37-40.

Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney
Radón V, Czesla M, Reichelt J, Fehlert J, Hammel A, Rosendahl A, Knop J, Wiech T, Wenzel U, Sachs M, Reinicke A, Stahl R, Meyer-Schwesinger C
KIDNEY INT. 2018;93(1):110-127.

Analysis of Risk Factors for Allograft Outcome Comparing 2 Kidneys From the Same Donor in Separate Recipients
Radtke J, Scheidat S, Achilles E, Li J, Fischer L, Herden U, Thaiss F, Wenzel U, Nashan B, Koch M
TRANSPL P. 2018;50(10):3211-3215.

Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IV
Schmieder R, Ott C, Toennes S, Bramlage P, Gertner M, Dawood O, Baumgart P, O'Brien B, Dasgupta I, Nickenig G, Ormiston J, Saxena M, Sharp A, Sievert H, Spinar J, Starek Z, Weil J, Wenzel U, Witkowski A, Lobo M
J HYPERTENS. 2018;36(3):680-689.

Diffusion-weighted imaging of the kidneys in haemolytic uraemic syndrome
Herrmann J, Wenzel U, Galler S, Schoennagel B, Busch J, Tozakidou M, Petersen K, Joekel M, Bannas P, Yamamura J, Groth M, Adam G, Habermann C
EUR RADIOL. 2017;27(11):4591-4601.

A pathogenic role of complement in arterial hypertension and hypertensive end organ damage
Wenzel U, Bode M, Köhl J, Ehmke H
AM J PHYSIOL-HEART C. 2017;312(3):H349-H354.

Disseminated Mycobacterium haemophilum infection in a renal transplant recipient
Brix S, Iking-Konert C, Stahl R, Wenzel U
BMJ CASE REP. 2016;2016:.

A Mechanism for Cancer-Associated Membranous Nephropathy
Hoxha E, Wiech T, Stahl P, Zahner G, Tomas N, Meyer-Schwesinger C, Wenzel U, Janneck M, Steinmetz O, Panzer U, Harendza S, Stahl R
NEW ENGL J MED. 2016;374(20):1995-6.

Autoimmune Renal Disease Is Exacerbated by S1P-Receptor-1-Dependent Intestinal Th17 Cell Migration to the Kidney
Krebs C, Paust H, Krohn S, Koyro T, Brix S, Riedel J, Bartsch P, Wiech T, Meyer-Schwesinger C, Huang J, Fischer N, Busch C, Mittrücker H, Steinhoff U, Stockinger B, Perez L, Wenzel U, Janneck M, Steinmetz O, Gagliani N, Stahl R, Huber S, Turner J, Panzer U
IMMUNITY. 2016;45(5):1078-1092.

The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension
Weiss S, Rosendahl A, Czesla D, Meyer-Schwesinger C, Stahl R, Ehmke H, Kurts C, Zipfel P, Köhl J, Wenzel U
AM J PHYSIOL-RENAL. 2016;310(11):F1356-65.

Immune Mechanisms in Arterial Hypertension
Wenzel U, Turner J, Krebs C, Kurts C, Harrison D, Ehmke H
J AM SOC NEPHROL. 2016;27(3):677-86.

Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations
Achelrod D, Wenzel U, Frey S
AM J HYPERTENS. 2015;28(3):355-61.

Differential impact of diabetes mellitus type II and arterial hypertension on collateral artery growth and concomitant macrophage accumulation
Ito W, Lund N, Sager H, Becker W, Wenzel U
VASA. 2015;44(1):31-41.

Renale Denervation bei nicht-kontrollierter arterieller Hypertonie
Vonend O, Böhm M, Eckert S, Hausberg M, Rittger H, Rump L, Schmieder R, Schulte K, Schunkert H, Uder M, Veelken R, Vorwerk D, Weil J, Wenzel U, Mahfoud F
DEUT MED WOCHENSCHR. 2015;140(5):363.

Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin ii-induced hypertension
Krebs C, Lange S, Niemann G, Rosendahl A, Lehners A, Meyer-Schwesinger C, Stahl R, Benndorf R, Velden J, Paust H, Panzer U, Ehmke H, Wenzel U
HYPERTENSION. 2014;63(3):565-71.

Myeloperoxidase deficiency ameliorates progression of chronic kidney disease in mice
Lehners A, Lange S, Niemann G, Rosendahl A, Meyer-Schwesinger C, Oh J, Stahl R, Ehmke H, Benndorf R, Klinke A, Baldus S, Wenzel U
AM J PHYSIOL-RENAL. 2014;307(4):F407-17.

Increased expression of (pro)renin receptor does not cause hypertension or cardiac and renal fibrosis in mice
Rosendahl A, Niemann G, Lange S, Ahadzadeh E, Krebs C, Contrepas A, van Goor H, Wiech T, Bader M, Schwake M, Peters J, Stahl R, Nguyen G, Wenzel U
LAB INVEST. 2014;94(8):863-72.

Shiga toxin-producing E. coli O104:H4 outbreak 2011 in Germany: radiological features of enterohemorrhagic colitis
Bannas P, Zimmermann-Fraedrich K, Treszl A, Bley T, Herrmann J, Habermann C, Derlin T, Henes F, Wenzel U, Adam G, Yamamura J
ROFO-FORTSCHR RONTG. 2013;185(5):434-9.

Aliskiren accumulation in the kidney: no major role for binding to renin or prorenin
Lange S, Fraune C, Alenina N, Bader M, Danser A, Frenay A, van Goor H, Stahl R, Nguyen G, Schwedhelm E, Wenzel U
J HYPERTENS. 2013;31(4):713-9.

Treatment of arterial hypertension in obese patients
Wenzel U, Benndorf R
SEMIN NEPHROL. 2013;33(1):66-74.

AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Fraune C, Lange S, Krebs C, Hölzel A, Baucke J, Divac N, Schwedhelm E, Streichert T, Velden J, Garrelds I, Danser A, Frenay A, van Goor H, Jankowski V, Stahl R, Nguyen G, Wenzel U
AM J PHYSIOL-RENAL. 2012;303(7):1037-1048.

CCR5 deficiency does not reduce hypertensive end-organ damage in mice
Krebs C, Fraune C, Schmidt-Haupt R, Turner J, Panzer U, Quang M, Tannapfel A, Velden J, Stahl R, Wenzel U
AM J HYPERTENS. 2012;25(4):479-486.

Therapie des typischen hämolytisch-urämischen Syndroms. Erkenntnisse aus dem E.-coli-Ausbruch 2011
Menne J, Kielstein J, Wenzel U, Stahl R
INTERNIST. 2012;53(12):1420-1430.

Hypertonie--auch 2012 eine Herausforderung
Potthoff S, Wenzel U, Kintscher U
DEUT MED WOCHENSCHR. 2012;137(48):2475.

Dimethylarginine dimethylaminohydrolase1 is an organ-specific mediator of end organ damage in a murine model of hypertension.
Sydow K, Schmitz C, von Leitner E, von Leitner R, Klinke A, Atzler D, Krebs C, Wieboldt H, Ehmke H, Schwedhelm E, Meinertz T, Blankenberg S, Böger R, Magnus T, Baldus S, Wenzel U
PLOS ONE. 2012;7(10):48150.

Kreatininanstieg bei einem 85-jährigen Patienten mit INR-Entgleisung
von Lewinski M, Helmchen U, Wenzel U
NEPHROLOGE. 2012;7(2):155-159.

Leishmania major parasite stage-dependent host cell invasion and immune evasion.
Wenzel U, Bank E, Florian C, Förster S, Zimara N, Steinacker J, Klinger M, Reiling N, Ritter U, van Zandbergen G
FASEB J. 2012;26(1):29-39.

A simple test to appreciate compliance with antihypertensive drug therapy
Wenzel U, Stange D, Düsing R
J HYPERTENS. 2012;30(3):625.

Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy.
Büchner N, Quack I, Woznowski M, Stähle C, Wenzel U, Rump L
RESPIRATION. 2011;82(5):409-417.

Podocytes of AT2 receptor knockout mice are protected from angiotensin II-mediated RAGE induction
Rüster C, Franke S, Wenzel U, Schmidthaupt R, Fraune C, Krebs C, Wolf G
AM J NEPHROL. 2011;34(4):309-317.

Hautnekrosen bei einer Dialysepatientin
Meyer T, Schröter C, Herberger K, Wenzel U
NEPHROLOGE. 2010;5(5):412-416.

Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation.
Rudolph V, Andrié R, Rudolph T, Friedrichs K, Klinke A, Hirsch-Hoffmann B, Schwoerer A, Lau D, Fu X, Klingel K, Sydow K, Didié M, Seniuk A, von Leitner E, Szöcs K, Schrickel J, Treede H, Wenzel U, Lewalter T, Nickenig G, Zimmermann W, Meinertz T, Böger R, Reichenspurner H, Freeman B, Eschenhagen T, Ehmke H, Hazen S, Willems S, Baldus S
NAT MED. 2010;16(4):470-474.

The angiotensin II type 2 receptor in renal disease.
Wenzel U, Krebs C, Benndorf R
J RENIN-ANGIO-ALDO S. 2010;11(1):37-41.

Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice.
Benndorf R, Krebs C, Hirsch-Hoffmann B, Schwedhelm E, Cieslar G, Schmidt-Haupt R, Steinmetz O, Meyer-Schwesinger C, Thaiss F, Haddad M, Fehr S, Heilmann A, Helmchen U, Hein L, Ehmke H, Stahl R, Böger R, Wenzel U
KIDNEY INT. 2009;75(10):1039-1049.

Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-kappaB p65 signaling.
Meyer-Schwesinger C, Silke D, von Ruffer C, Gatzemeier S, Klug P, Wenzel U, Stahl R, Thaiss F, Meyer T
AM J PHYSIOL-RENAL. 2009;296(5):1088-1099.

Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II.
Kirchhoff F, Krebs C, Abdulhag U, Meyer-Schwesinger C, Maas R, Helmchen U, Hilgers K, Wolf G, Stahl R, Wenzel U
KIDNEY INT. 2008;73(5):643-650.

Effect of (pro)renin receptor inhibition by a decoy peptide on renal damage in the clipped kidney of Goldblatt rats.
Krebs C, Weber M, Steinmetz O, Meyer-Schwesinger C, Stahl R, Danser A, Garrelds I, van Goor H, Nguyen G, Müller D, Wenzel U
KIDNEY INT. 2008;74(6):823-824.

CCR5 deficiency aggravates crescentic glomerulonephritis in mice.
Turner J, Paust H, Steinmetz O, Peters A, Meyer-Schwesinger C, Heymann F, Helmchen U, Fehr S, Horuk R, Wenzel U, Kurts C, Mittrücker H, Stahl R, Panzer U
J IMMUNOL. 2008;181(9):6546-6556.

Aldosterone and progression of renal disease.
Wenzel U
CURR OPIN NEPHROL HY. 2008;17(1):44-50.

[Quality of life under antihypertensive therapy: essentially for compliance]
Wenzel U, Krebs C
MMW Fortschr Med. 2008;150(24):30-32.

Telmisartan improves endothelial function in patients with essential hypertension.
Benndorf R, Appel D, Maas R, Schwedhelm E, Wenzel U, Böger R
J CARDIOVASC PHARM. 2007;50(4):367-371.

Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats.
Krebs C, Hamming I, Sadaghiani S, Steinmetz O, Meyer-Schwesinger C, Fehr S, Stahl R, Garrelds I, Danser A, van Goor H, Contrepas A, Nguyen G, Wenzel U
KIDNEY INT. 2007;72(6):725-730.

A pitfall of glomerular sieving: profibrotic and matrix proteins derive from the Bowman's capsule and not the glomerular tuft in rats with renovascular hypertension.
Steinmetz O, Panzer U, Fehr S, Meyer-Schwesinger C, Stahl R, Wenzel U
NEPHROL DIAL TRANSPL. 2007;22(10):3055-3060.

Antihypertensive therapy induces compartment-specific chemokine expression and a Th1 immune response in the clipped kidney of Goldblatt hypertensive rats.
Steinmetz O, Sadaghiani S, Panzer U, Krebs C, Meyer-Schwesinger C, Streichert T, Fehr S, Hamming I, van Goor H, Stahl R, Wenzel U
AM J PHYSIOL-RENAL. 2007;292(2):876-887.

Aldosterone antagonists: silver bullet or just sodium excretion and potassium retention?
Wenzel U
KIDNEY INT. 2007;71(5):374-376.

Management of arterial hypertension in obese patients.
Wenzel U, Krebs C
CURR HYPERTENS REP. 2007;9(6):491-497.

Statin therapy in patients with chronic kidney disease: to use or not to use.
Steinmetz O, Panzer U, Stahl R, Wenzel U
EUR J CLIN INVEST. 2006;36(8):519-527.

Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction.
Weil J, Zolk O, Griepentrog J, Wenzel U, Zimmermann W, Eschenhagen T
CARDIOVASC RES. 2006;69(2):412-422.

My doctor said I should drink a lot! Recommendations for fluid intake in patients with chronic kidney disease.
Wenzel U, Hebert L, Stahl R, Krenz I
CLIN J AM SOC NEPHRO. 2006;1(2):344-346.

Massive bleeding after biopsy of a renal allograft.
Wenzel U, Helmchen U, Stahl R, Nolte-Ernsting C
KIDNEY INT. 2006;69(7):1101.

A patient with autosomal dominant polycystic kidney and liver disease presenting with urinary tract infection...'Unable to see the wood for the trees'.
Wenzel U, Janneck M, Weber C, Stahl R, Brenner W
NEPHROL DIAL TRANSPL. 2006;21(8):2333-2334.

Angiotensin II upregulates toll-like receptor 4 on mesangial cells.
Wolf G, Bohlender J, Bondeva T, Roger T, Thaiss F, Wenzel U
J AM SOC NEPHROL. 2006;17(6):1585-1593.

Angiotensin II down-regulates the SR-BI HDL receptor in proximal tubular cells.
Wolf G, Wenzel U, Jablonski K, Brundert M, Rinninger F
NEPHROL DIAL TRANSPL. 2005;20(6):1222-1227.

Angiotensin II and cell cycle regulation.
Wolf G, Wenzel U
HYPERTENSION. 2004;43(4):693-698.

Beneficial and adverse renal and vascular effects of the vasopeptidase inhibitor omapatrilat in renovascular hypertensive rats.
Wenzel U, Wolf G, Jacob I, Schwegler C, Qasqas A, Amann K, Helmchen U, Stahl R
NEPHROL DIAL TRANSPL. 2003;18(10):2005-2013.

The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology.
Wolf G, Butzmann U, Wenzel U
NEPHRON PHYSIOL. 2003;93(1):3-13.

[48-year-old patient with right sided flank pain and hypertension of recent onset. Secondary hypertension caused by embolic renal infarcts due to dissecting renal artery aneurysms]
Ameis D, Knolinski T, Guthoff A, Wenzel U, Greten H
INTERNIST. 2002;43(9):1129-1132.

Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis.
Wenzel U, Thaiss F, Helmchen U, Stahl R, Wolf G
KIDNEY INT. 2002;61(3):1020-1029.

Chronic anti-Thy-1 nephritis is aggravated in the nonclipped but not in the clipped kidney of Goldblatt hypertensive rats.
Wenzel U, Wolf G, Jacob I, Thaiss F, Helmchen U, Stahl R
KIDNEY INT. 2002;61(6):2119-2131.

Angiotensin II's antiproliferative effects mediated through AT2-receptors depend on down-regulation of SM-20.
Wolf G, Harendza S, Schroeder R, Wenzel U, Zahner G, Butzmann U, Freeman R, Stahl R
LAB INVEST. 2002;82(10):1305-1317.

No association between a genetic variant of the p22(phox) component of NAD(P)H oxidase and the incidence and progression of IgA nephropathy.
Wolf G, Panzer U, Harendza S, Wenzel U, Stahl R
NEPHROL DIAL TRANSPL. 2002;17(8):1509-1512.

Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors.
Wolf G, Wenzel U, Burns K, Harris R, Stahl R, Thaiss F
KIDNEY INT. 2002;61(6):1986-1995.

Angiotensin-converting enzyme inhibitors and progression of renal disease: evidence from clinical studies.
Wenzel U
CONTRIB NEPHROL. 2001;135:200-211.

[The treatment of arterial hypertension. An inquiry among doctors in general practice]
Wenzel U, Röben T, Schwietzer G, Stahl R
DEUT MED WOCHENSCHR. 2001;126(51-52):1454-1459.

Angiotensin II induces p27(Kip1) expression in renal tubules in vivo: role of reactive oxygen species.
Wolf G, Wenzel U, Hannken T, Stahl R
J MOL MED. 2001;79(7):382-389.

[Hypertensive disorders in pregnancy]
Wolf G, Wenzel U, Stahl R, Hüneke B
MED KLIN-INTENSIVMED. 2001;96(2):78-86.

Renovascular hypertension does not influence repair of glomerular lesions induced by anti-thymocyte glomerulonephritis.
Wenzel U, Wolf G, Thaiss F, Helmchen U, Stahl R
KIDNEY INT. 2000;58(3):1135-1147.

Renal expression of aminopeptidase A in rats with two-kidney, one-clip hypertension.
Wolf G, Wenzel U, Assmann K, Stahl R
NEPHROL DIAL TRANSPL. 2000;15(12):1935-1942.

Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C.
Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl R, MacHarzina R, Bräsen J, Meinertz T, Münzel T
KIDNEY INT. 1999;55(1):252-260.

Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E.
Marra F, DeFranco R, Grappone C, Parola M, Milani S, Leonarduzzi G, Pastacaldi S, Wenzel U, Pinzani M, Dianzani M, Laffi G, Gentilini P
J INVEST MED. 1999;47(1):66-75.

Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis.
Schneider A, Harendza S, Zahner G, Jocks T, Wenzel U, Wolf G, Thaiss F, Helmchen U, Stahl R
KIDNEY INT. 1999;55(2):430-441.

Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-beta.
Schneider A, Panzer U, Zahner G, Wenzel U, Wolf G, Thaiss F, Helmchen U, Stahl R
KIDNEY INT. 1999;56(1):135-144.

[A 73-year-old patient with hypertensive crisis. Was the use of calcium antagonist nifedipine justified?]
Wenzel U, Pfalzer B, Meinertz T, Stahl R
INTERNIST. 1999;40(2):205-209.

Chemokines, renal disease, and HIV infection.
Wenzel U, Stahl R
NEPHRON. 1999;81(1):5-16.

Effect of renovascular hypertension on experimental glomerulonephritis in rats.
Wenzel U, Thaiss F, Panzer U, Schneider A, Schwietzer G, Helmchen U, Stahl R
J LAB CLIN MED. 1999;134(3):292-303.

Angiotensin converting-enzyme inhibitor treatment reduces glomerular p16INK4 and p27Kip1 expression in diabetic BBdp rats.
Wolf G, Wenzel U, Ziyadeh F, Stahl R
DIABETOLOGIA. 1999;42(12):1425-1432.

L-arginine suppresses lipopolysaccharide-induced expression of RANTES in glomeruli.
Haberstroh U, Stilo K, Pocock J, Wolf G, Helmchen U, Wenzel U, Zahner G, Stahl R, Thaiss F
J AM SOC NEPHROL. 1998;9(2):203-210.

A complex element regulates IFN-gamma-stimulated monocyte chemoattractant protein-1 gene transcription.
Valente A, Xie J, Abramova M, Wenzel U, Abboud H, Graves D
J IMMUNOL. 1998;161(7):3719-3728.

Regulation of glomerular TGF-beta expression in the contralateral kidney of two-kidney, one-clip hypertensive rats.
Wolf G, Schneider A, Wenzel U, Helmchen U, Stahl R
J AM SOC NEPHROL. 1998;9(5):763-772.

Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis.
Wenzel U, Schneider A, Valente A, Abboud H, Thaiss F, Helmchen U, Stahl R
KIDNEY INT. 1997;51(3):770-776.

Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor.
Wolf G, Ziyadeh F, Thaiss F, Tomaszewski J, Caron R, Wenzel U, Zahner G, Helmchen U, Stahl R
J CLIN INVEST. 1997;100(5):1047-1058.

Role of chemokines in glomerular diseases.
Banas B, Wenzel U, Stahl R, Schlöndorff D
KIDNEY BLOOD PRESS R. 1996;19(5):270-280.

Angiotensin-converting enzyme inhibition in experimental in-situ immune complex glomerulonephritis: influence on renal function, proteinuria, and morphology.
Thaiss F, Haas C, Helmchen U, Wenzel U, Stahl R
NEPHROL DIAL TRANSPL. 1996;11(1):40-46.

A nuclear protein in mesangial cells that binds to the promoter region of the platelet-derived growth factor-A chain gene. Induction by phorbol ester.
Bhandari B, Wenzel U, Marra F, Abboud H
J BIOL CHEM. 1995;270(10):5541-5548.

PKC alpha regulates thrombin-induced PDGF-B chain gene expression in mesangial cells.
Biswas P, Abboud H, Kiyomoto H, Wenzel U, Grandaliano G, Choudhury G
FEBS LETT. 1995;373(2):146-150.

Chemokines and renal disease.
Wenzel U, Abboud H
AM J KIDNEY DIS. 1995;26(6):982-994.

Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy.
Wenzel U, Fouqueray B, Biswas P, Grandaliano G, Choudhury G, Abboud H
J CLIN INVEST. 1995;95(3):1244-1252.

Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells.
Wenzel U, Fouqueray B, Grandaliano G, Kim Y, Karamitsos C, Valente A, Abboud H
CIRC RES. 1995;77(3):503-509.

Combination treatment of enalapril with nitrendipine in rats with renovascular hypertension.
Wenzel U, Helmchen U, Schoeppe W, Schwietzer G
HYPERTENSION. 1994;23(1):114-122.

Morphologic and functional consequences of immune-mediated mesangiolysis: development of chronic glomerular sclerosis.
Stahl R, Thaiss F, Wenzel U, Helmchen U
J AM SOC NEPHROL. 1992;2(10):144-148.

A rat model of progressive chronic glomerular sclerosis: the role of thromboxane inhibition.
Stahl R, Thaiss F, Wenzel U, Schoeppe W, Helmchen U
J AM SOC NEPHROL. 1992;2(11):1568-1577.

Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension.
Wenzel U, Troschau G, Schoeppe W, Helmchen U, Schwietzer G
HYPERTENSION. 1992;20(2):233-241.

The platelet activating factor receptor antagonist WEB 2170 improves glomerular hemodynamics and morphology in a proliferative model of mesangial cell injury.
Stahl R, Thaiss F, Oberle G, Brecht H, Schoeppe W, Wenzel U, Helmchen U
J AM SOC NEPHROL. 1991;2(1):37-44.

Letzte Aktualisierung aus dem FIS: 20.11.2024 - 23:35 Uhr